422
Views
1
CrossRef citations to date
0
Altmetric
Supplement 2, 2012

Isolation of bifidobacteria for blood group secretor status targeted personalised nutrition

, , , , , & show all
Article: 18578 | Published online: 18 Jun 2012

References

  • Dethlefsen L, Eckburg PB, Bik EM, Relman DA. Assembly of the human intestinal microbiota. Trends Ecol Evol. 2006; 21: 517–23. 10.3402/mehd.v23i0.18578.
  • Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009; 9: 313–23. 10.3402/mehd.v23i0.18578.
  • Zoetendal EG, Ben-Amor K, Akkermans AD, Abee T, de Vos WM. DNA isolation protocols affect the detection limit of PCR approaches of bacteria in samples from the human gastrointestinal tract. Syst Appl Microbiol. 2001; 24: 405–10. 10.3402/mehd.v23i0.18578.
  • Wacklin P, Makivuokko H, Alakulppi N, Nikkila J, Tenkanen H, Rabina J, et al. Secretor genotype (FUT2 gene) is strongly associated with the composition of Bifidobacteria in the human intestine. PLoS One. 2011; 6: e20113. 10.3402/mehd.v23i0.18578.
  • Boren T, Falk P, Roth KA, Larson G, Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science. 1993; 262: 1892–5. 10.3402/mehd.v23i0.18578.
  • Hoskins LC, Agustines M, McKee WB, Boulding ET, Kriaris M, Niedermeyer G. Mucin degradation in human colon ecosystems. Isolation and properties of fecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins. J Clin Invest. 1985; 75: 944–53. 10.3402/mehd.v23i0.18578.
  • Moulds JM, Nowicki S, Moulds JJ, Nowicki BJ. Human blood groups: incidental receptors for viruses and bacteria. Transfusion. 1996; 36: 362–74. 10.3402/mehd.v23i0.18578.
  • Henry SM. Review: phenotyping for Lewis and secretor histo-blood group antigens. Immunohematology. 1996; 12: 51–61.
  • Eriksson AW, Partanen K, Frants RR, Pronk JC, Kostense PJ. ABH secretion polymorphism in Icelanders, Aland Islanders, Finns, Finnish Lapps, Komi and Greenland Eskimos: a review and new data. Ann Hum Biol. 1986; 13: 273–85. 10.3402/mehd.v23i0.18578.
  • Silva LM, Carvalho AS, Guillon P, Seixas S, Azevedo M, Almeida R, et al. Infection-associated FUT2 (Fucosyltransferase 2) genetic variation and impact on functionality assessed by in vivo studies. Glycoconj J. 2010; 7: 61–8. 10.3402/mehd.v23i0.18578.
  • McGovern DP, Jones MR, Taylor KD, Marciante K, Yan X, Dubinsky M, et al. Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. Hum Mol Genet. 2010; 19: 3468–76. 10.3402/mehd.v23i0.18578.
  • Thorven M, Grahn A, Hedlund KO, Johansson H, Wahlfrid C, Larson G, et al. A homozygous nonsense mutation (428G→A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J Virol. 2005; 79: 15351–5. 10.3402/mehd.v23i0.18578.
  • Hurd EA, Domino SE. Increased susceptibility of secretor factor gene Fut2-null mice to experimental vaginal candidiasis. Infect Immun. 2004; 72: 4279–81. 10.3402/mehd.v23i0.18578.
  • Ronchetti F, Villa MP, Ronchetti R, Bonci E, Latini L, Pascone R, et al. ABO/secretor genetic complex and susceptibility to asthma in childhood. Eur Respir J. 2001; 17: 1236–8. 10.3402/mehd.v23i0.18578.
  • Sheinfeld J, Schaeffer AJ, Cordon-Cardo C, Rogatko A, Fair WR. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N Engl J Med. 1989; 320: 773–7. 10.3402/mehd.v23i0.18578.
  • Guillon P, Ruvoen-Clouet N, Le Moullac-Vaidye B, Marchandeau S, Le Pendu J. Association between expression of the H histo-blood group antigen, alpha1,2fucosyltransferases polymorphism of wild rabbits, and sensitivity to rabbit hemorrhagic disease virus. Glycobiology. 2009; 19: 21–8. 10.3402/mehd.v23i0.18578.
  • Minekus M, Marteau P, Havenaar R, Huis in't Veld JHJ. A multi-compartmental dynamic computer-controlled model simulating the stomach and small intestine. Altern Lab Anim. 1995; 23: 197–209.
  • Ferrer-Admetlla A, Sikora M, Laayouni H, Esteve A, Roubinet F, Blancher A, et al. A natural history of FUT2 polymorphism in humans. Mol Biol Evol. 2009; 26: 1993–2003. 10.3402/mehd.v23i0.18578.
  • Marteau P, Minekus M, Havenaar R, Huis in't Veld JH. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. J Dairy Sci. 1997; 80: 1031–7. 10.3402/mehd.v23i0.18578.
  • Matto J, Malinen E, Suihko ML, Alander M, Palva A, Saarela M. Genetic heterogeneity and functional properties of intestinal bifidobacteria. J Appl Microbiol. 2004; 97: 459–70. 10.3402/mehd.v23i0.18578.
  • Saarela M, Rantala M, Hallamaa K, Nohynek L, Virkajarvi I, Matto J. Stationary-phase acid and heat treatments for improvement of the viability of probiotic lactobacilli and bifidobacteria. J Appl Microbiol. 2004; 96: 1205–14. 10.3402/mehd.v23i0.18578.
  • Rausch P, Rehman A, Kunzel S, Hasler R, Ott SJ, Schreiber S, et al. Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc Natl Acad Sci U S A. 2011; 108: 19030–5. 10.3402/mehd.v23i0.18578.